Dr. Monica Pasternak

About

Every cycle Spring Fertility reports to SART is filed under one registered clinic unit, ClinicPKID 2000045, and the medical director named on that registration record is Monica Pasternak. That is the accountability position in a fertility practice. It is the role answerable for lab standards, consent and outcome reporting, and it means the physician who signs the numbers you can look up on SART CORS also sees patients at the Pacific Heights office.

Her route into that seat was not the standard pre-med path. She grew up in Westport, Connecticut, and studied Middle East and South Asian Studies at Columbia University with a minor in biology. At the University of Miami she took a combined degree — an MD and an MBA — before obstetrics and gynecology residency at Yale and a fellowship in Reproductive Endocrinology and Infertility at Cornell. The dual degree is the unusual piece: clinical training paired with management training, in a practice that has scaled from one San Francisco clinic to offices in California, New York and Oregon.

Her named clinical interests skew toward the cases that resist a standard explanation: immunologic disorders affecting reproduction, recurrent pregnancy loss, endometriosis, fertility preservation, and innovative assisted reproductive technologies, plus global health. She is the only physician in Spring’s San Francisco group whose profile pairs that interests list with the medical director designation.

Clinical Expertise

• Third-party reporting accountability: medical director named on Spring’s SART clinic registration and its outcome submissions
• Immunologic infertility and recurrent pregnancy loss: reproductive immune dysfunction and repeated loss, listed together as a focus area
• Endometriosis-related infertility: a stated clinical interest in her practice profile
• Fertility preservation: egg and embryo freezing
• IVF and assisted reproductive technology: including her stated interest in innovative ART approaches
• Program and practice operations: MD/MBA training applied to a multi-state clinic group

Why Choose Dr. Pasternak

You can see who signs the data. Choosing the physician named as medical director on the SART record means your treating doctor is the person responsible for the lab and reporting standards behind the clinic’s published outcomes.

Recurrent loss and immune factors are her lane. Immunologic disorders affecting reproduction and recurrent pregnancy loss appear as a combined interest — the workup most often needed after multiple losses without a cause.

Business training alongside clinical training. A combined MD/MBA from Miami, Yale residency and Cornell fellowship is an uncommon combination when you want a physician who understands what a growing multi-state practice can and cannot commit to on cost, staffing and lab capacity.

A nontraditional academic background. A Columbia degree in Middle East and South Asian Studies, plus a stated global-health interest, shows up with international patients and cross-border family-building questions.

Professional Affiliations

Medical director of record for Spring Fertility’s SART-registered unit (ClinicPKID 2000045), which reports cycles and outcomes to SART CORS and whose laboratory is recorded as CAP-accredited. Education: Columbia University; University of Miami (MD, MBA); residency in Obstetrics and Gynecology at Yale; fellowship in Reproductive Endocrinology and Infertility at Cornell. Note: her Spring biography and the SART registration document fellowship training and the medical-director designation rather than board certification; verify current certification with the American Board of Obstetrics and Gynecology if that is a deciding factor.

Suitable For

• Patients with two or more pregnancy losses and no identified cause, particularly where immune factors are being considered
• Endometriosis patients facing infertility
• Egg freezing and IVF patients who want their physician to be accountable for the lab behind the program
• Complex or previously failed cases where practice-level judgment about protocols and lab capability matters
• International patients whose family building crosses borders